Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Optimal designs for two-arm, phase II clinical trial design with multiple constraints.

Mayo MS, Mahnken JD, Soong SJ.

J Biopharm Stat. 2010 Jan;20(1):106-24. doi: 10.1080/10543400903280597.

PMID:
20077252
2.

Design issues of randomized phase II trials and a proposal for phase II screening trials.

Rubinstein LV, Korn EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA.

J Clin Oncol. 2005 Oct 1;23(28):7199-206.

PMID:
16192604
3.
4.

Optimal and minimax three-stage designs for phase II oncology clinical trials.

Chen K, Shan M.

Contemp Clin Trials. 2008 Jan;29(1):32-41. Epub 2007 May 6.

PMID:
17544337
5.

Randomized phase II trials with a prospective control.

Jung SH.

Stat Med. 2008 Feb 20;27(4):568-83.

PMID:
17573688
6.

Optimal two-stage randomized multinomial designs for Phase II oncology trials.

Sun LZ, Chen C, Patel K.

J Biopharm Stat. 2009;19(3):485-93. doi: 10.1080/10543400902802417.

PMID:
19384690
7.

Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.

Shan G, Ma C, Hutson AD, Wilding GE.

J Biopharm Stat. 2013;23(5):1081-90. doi: 10.1080/10543406.2013.813525.

PMID:
23957517
8.

An efficient algorithm to determine the optimal two-stage randomized multinomial designs in oncology clinical trials.

Zhang Y, Mietlowski W, Chen B, Wang Y.

J Biopharm Stat. 2011 Jan;21(1):56-65. doi: 10.1080/10543400903541097.

PMID:
21191854
9.

Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.

Gray R, Manola J, Saxman S, Wright J, Dutcher J, Atkins M, Carducci M, See W, Sweeney C, Liu G, Stein M, Dreicer R, Wilding G, DiPaola RS.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1966-9. Review.

10.

Optimising the design of phase II oncology trials: the importance of randomisation.

Ratain MJ, Sargent DJ.

Eur J Cancer. 2009 Jan;45(2):275-80. doi: 10.1016/j.ejca.2008.10.029. Epub 2008 Dec 6.

PMID:
19059773
11.

Improving the design of phase II trials of cytostatic anticancer agents.

Stone A, Wheeler C, Barge A.

Contemp Clin Trials. 2007 Feb;28(2):138-45. Epub 2006 Jul 14. Review.

PMID:
16843736
12.

Adaptive two-stage designs in phase II clinical trials.

Banerjee A, Tsiatis AA.

Stat Med. 2006 Oct 15;25(19):3382-95.

PMID:
16479547
13.

Early selection in a randomized phase II clinical trial.

Steinberg SM, Venzon DJ.

Stat Med. 2002 Jun 30;21(12):1711-26.

PMID:
12111907
14.

New designs for the selection of treatments to be tested in randomized clinical trials.

Simon R, Thall PF, Ellenberg SS.

Stat Med. 1994 Mar 15-Apr 15;13(5-7):417-29. Review.

PMID:
8023026
15.

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

Pond GR, Abbasi S.

Clin Trials. 2011 Jun;8(3):260-9. doi: 10.1177/1740774511401764. Epub 2011 Apr 20.

PMID:
21511687
16.

An efficient multiple-stage procedure for phase II clinical trials that have high response rate objectives.

Chen S, Soong SJ, Wheeler RH.

Control Clin Trials. 1994 Aug;15(4):277-83.

PMID:
7956267
17.

Performance of adaptive designs for single-armed phase II oncology trials.

Kieser M, Englert S.

J Biopharm Stat. 2015;25(3):602-15. doi: 10.1080/10543406.2014.920863.

PMID:
24905363
18.

Seamless Phase II/III combination study through response adaptive randomization.

Wang L, Cui L.

J Biopharm Stat. 2007;17(6):1177-87.

PMID:
18027224
19.

Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.

Tang H, Foster NR, Grothey A, Ansell SM, Goldberg RM, Sargent DJ.

J Clin Oncol. 2010 Apr 10;28(11):1936-41. doi: 10.1200/JCO.2009.25.5489. Epub 2010 Mar 8.

20.

Graphical search for two-stage designs for phase II clinical trials.

Jung SH, Carey M, Kim KM.

Control Clin Trials. 2001 Aug;22(4):367-72.

PMID:
11514038

Supplemental Content

Support Center